ArticleOphthalmology and therapy2026
Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study.
Filipe Mira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.